249 related articles for article (PubMed ID: 19012704)
1. Possible risk factor for postmenopausal women: postprandial hypertriglyceridemia.
Yoshikata R; Miyahara Y; Onoe Y; Okano H; Ohta H
J Obstet Gynaecol Res; 2008 Dec; 34(6):1032-6. PubMed ID: 19012704
[TBL] [Abstract][Full Text] [Related]
2. [Postprandial changes of blood lipid after ordinary Chinese diet and the influencing factors thereof].
Fu ZF; Liu ML
Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(4):260-2. PubMed ID: 19552844
[TBL] [Abstract][Full Text] [Related]
3. Postprandial lipaemia in menopausal women with metabolic syndrome.
Kolovou GD; Anagnostopoulou KK; Pavlidis AN; Salpea KD; Hoursalas IS; Manolis A; Cokkinos DV
Maturitas; 2006 Aug; 55(1):19-26. PubMed ID: 16443339
[TBL] [Abstract][Full Text] [Related]
4. Fasting triglyceride is a major determinant of postprandial triglyceride response in postmenopausal women.
Hwu CM; Lin MW; Liou TL; Hsiao LC; Liang KW; Tsai TT; Ho LT
Menopause; 2008; 15(1):150-6. PubMed ID: 17549035
[TBL] [Abstract][Full Text] [Related]
5. The influence of natural menopause on postprandial lipemia in heterozygotes for familial hypercholesterolemia.
Kolovou GD; Anagnostopoulou KK; Pilatis ND; Giannopoulou M; Hoursalas IS; Pavlidis AN; Adamopoulou E; Valaora AI; Mikhailidis DP; Cokkinos DV
J Womens Health (Larchmt); 2004 Dec; 13(10):1119-26. PubMed ID: 15650345
[TBL] [Abstract][Full Text] [Related]
6. Estimating the fasting triglyceride concentration from the postprandial HDL-cholesterol and apolipoprotein CIII concentrations.
Kosuge K; Miida T; Takahashi A; Obayashi K; Ito M; Ito T; Soda S; Ozaki K; Hirayama S; Hanyu O; Aizawa Y; Nakamura Y
Atherosclerosis; 2006 Feb; 184(2):413-9. PubMed ID: 16024022
[TBL] [Abstract][Full Text] [Related]
7. Triglyceride profile in dyslipidaemia of type 2 diabetes mellitus.
Khan SR; Ayub N; Nawab S; Shamsi TS
J Coll Physicians Surg Pak; 2008 May; 18(5):270-3. PubMed ID: 18541079
[TBL] [Abstract][Full Text] [Related]
8. [Preheparin lipoprotein lipase mass and apolipoproteinC-III ratio helps identify postprandial triglyceride metabolic marker].
Miyake N; Miyake K; Higurashi H; Ohsaka A
Rinsho Byori; 2007 Nov; 55(11):1019-24. PubMed ID: 18154034
[TBL] [Abstract][Full Text] [Related]
9. Effects of E2 and E2/norgestimate hormone therapy on elevated baseline lipids.
Langer RD; Friedman AJ
J Reprod Med; 2006 Aug; 51(8):610-6. PubMed ID: 16967629
[TBL] [Abstract][Full Text] [Related]
10. HDL-associated apoCIII plays an independent role in predicting postprandial hypertriglyceridemia.
Zhang T; Tang X; Mao L; Chen J; Kuang J; Guo X; Xu D; Peng D; Yu B
Clin Biochem; 2020 May; 79():14-22. PubMed ID: 32045574
[TBL] [Abstract][Full Text] [Related]
11. Exacerbation of insulin resistance and postprandial triglyceride response in newly diagnosed hypertensive patients with hypertriglyceridaemia.
Hwu CM; Kwok CF; Kuo CS; Hsiao LC; Lee YS; Wei MJ; Kao WY; Lee SH; Ho LT
J Hum Hypertens; 2002 Jul; 16(7):487-93. PubMed ID: 12080433
[TBL] [Abstract][Full Text] [Related]
12. Relation of triglyceride levels, fasting and nonfasting, to fatal and nonfatal coronary heart disease.
Eberly LE; Stamler J; Neaton JD;
Arch Intern Med; 2003 May; 163(9):1077-83. PubMed ID: 12742806
[TBL] [Abstract][Full Text] [Related]
13. Effects of raloxifene on lipid and lipoprotein levels in postmenopausal osteoporotic women with and without hypertriglyceridemia.
Dayspring T; Qu Y; Keech C
Metabolism; 2006 Jul; 55(7):972-9. PubMed ID: 16784972
[TBL] [Abstract][Full Text] [Related]
14. Prescription omega-3-acid ethyl esters reduce fasting and postprandial triglycerides and modestly reduce pancreatic β-cell response in subjects with primary hypertriglyceridemia.
Maki KC; Lawless AL; Kelley KM; Dicklin MR; Schild AL; Rains TM
Prostaglandins Leukot Essent Fatty Acids; 2011; 85(3-4):143-8. PubMed ID: 21775113
[TBL] [Abstract][Full Text] [Related]
15. Correlation of non-high-density lipoprotein cholesterol and low-density lipoprotein cholesterol with apolipoprotein B during simvastatin + fenofibrate therapy in patients with combined hyperlipidemia (a subanalysis of the SAFARI trial).
Grundy SM; Vega GL; Tomassini JE; Tershakovec AM
Am J Cardiol; 2009 Aug; 104(4):548-53. PubMed ID: 19660610
[TBL] [Abstract][Full Text] [Related]
16. Experimental model of postprandial hypertriglyceridemia in sucrose-fed rats and the effectiveness of atorvastatin in the model.
Funatsu T; Kakuta H; Takasu T; Noguchi M; Suzuki M; Miyata K
Metabolism; 2003 May; 52(5):609-15. PubMed ID: 12759892
[TBL] [Abstract][Full Text] [Related]
17. Gender differences in the lipid profile of dyslipidemic subjects.
Kolovou GD; Anagnostopoulou KK; Damaskos DS; Bilianou HI; Mihas C; Milionis HJ; Kostakou PM; Cokkinos DV
Eur J Intern Med; 2009 Mar; 20(2):145-51. PubMed ID: 19327602
[TBL] [Abstract][Full Text] [Related]
18. Comparison of 2 homogeneous high-density lipoprotein cholesterol assays.
Hoang MP; Hirany SV; Parupia J; Devaraj S; Jialal I
Arch Pathol Lab Med; 1998 Nov; 122(11):1005-9. PubMed ID: 9822130
[TBL] [Abstract][Full Text] [Related]
19. Effects of bezafibrate on HDL2/HDL3 ratio in postmenopausal hypertriglyceridemic women.
Ushiroyama T; Sakuma K; Nosaka S
J Cardiovasc Pharmacol Ther; 2006 Jun; 11(2):142-8. PubMed ID: 16891292
[TBL] [Abstract][Full Text] [Related]
20. Melatonin treatment in peri- and postmenopausal women elevates serum high-density lipoprotein cholesterol levels without influencing total cholesterol levels.
Tamura H; Nakamura Y; Narimatsu A; Yamagata Y; Takasaki A; Reiter RJ; Sugino N
J Pineal Res; 2008 Aug; 45(1):101-5. PubMed ID: 18298467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
